National Preferred Flex Formulary: Built for the Evolution of Drug Pricing
Our National Preferred Flex Formulary provides employers and health plans a pathway to cover lower list-price products; helps deliver lower member out-of-pocket costs; and reduces reliance on branded-...
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in June 2020. (Estimated Reading Time: ~10 mins.)
Indication-specific pricing makes therapy more affordable and accessible for all patients by aligning payment for a drug with the value it delivers to a particular patient population.
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in July 2020. (Estimated Reading Time: ~10 mins.)
A Call for A Consensus: Price Increases in Branded Drugs Are Unsustainable
Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.
2019 National Preferred Formulary: Better Access. Better Value.
Our National Preferred Formulary will provide payers and their members access to 3,886 medications while saving $3.2 billion on their prescription drug bill.
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in August 2020. (Estimated Reading Time: ~10 mins.)
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in December 2020.
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in November 2020.
